3 min. Read

Preview of Proteus Report. Akili gets FDA OK (finally).

Issue 057.

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote about Haven's health coaching partner going public. Next week I am open to ideas -- what should E&O dig into? Here's what's happening this week:

  • What a busy week. I pulled together The Proteus Digital Health Report after the long-running company filed for Chapter 11 bankruptcy on Monday. There's a bit more on that report below or just head to E&O to read the full 4,400-word report now.
  • The other big news this week: On Monday the FDA announced that it had (finally) granted Akili Interactive a De Novo clearance for EndeavorRx (AKL-T01), which is video game-based prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). Perhaps the most remarkable thing about this move by the FDA is that its database shows it only took TWO MONTHS from the time

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Cigna bought MDLIVE for $2B cash in 2021
6 min. Read
Pear bought Pear. New HCPCS attempts. Trials
8 min. Read
Pear sold for $6M. Woebot pauses PDTs. Swing-FDA
6 min. Read
Quest bought Pack Health for $123M cash. Trials
6 min. Read
New digital health CPT code hopefuls. Trials
5 min. Read
Breaking: Pear Therapeutics files for Chapter 11 bankruptcy
4 min. Read
Pricing Database update: 60+ digital health prices.
3 min. Read
E&O readers analyze fate of Pear, PDTs. FDA-AI
8 min. Read
Seven secret health tech funding deals
3 min. Read
FDA waiver ends Nov 7. Withings ScanWatch recall, revs
10 min. Read
  • First
  • Previous
  • 1 of 32
  • Next
  • Last